The vaccine trade is not over and has room run with an eventual approval bringing a one-off rise for markets, UBS strategists said.

from MarketWatch.com - Top Stories https://ift.tt/3lA7I20
via IFTTT
from MarketWatch.com - Top Stories https://ift.tt/3lA7I20
via IFTTT
Kommentare
Kommentar veröffentlichen